DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announceDALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce

New Outpatient Infusion Center Opening in Marietta, GA Expands the National Presence of Advanced Infusion Care

DALLAS–(BUSINESS WIRE)–Advanced Infusion Care (AIC), a division of AIS Healthcare and a leading provider of personalized infusion therapy, is pleased to announce the opening of another Advanced Infusion Care Center (AICC). This latest one is in Marietta, GA represents a significant step forward in AIC’s ongoing expansion and its commitment to increasing access to compassionate, high-quality infusion services across the country.

The opening of more and more AICC sites highlights AIC’s strategic dedication to addressing the rising demand for outpatient infusion therapy. Designed based on a modern, patient-focused approach, the Centers emphasize comfort, convenience, and clinical excellence. Now accepting referrals, the Marietta location is ready to deliver individualized infusion therapy to the patients who depend on these services in the greater Atlanta region.

“We are truly excited to open our new infusion Center in Marietta, GA as it represents another meaningful step in our mission to bring high-quality, personalized care closer to the patients who need it most,” said Simon Castellanos, CEO of AIS Healthcare. “This expansion allows us to better support the community while continuing to raise the standard for outpatient infusion services nationwide.”

Offering a wide range of therapies for both long-term and short-term conditions, AICC—including the Marietta location—ensure that patients have access to the newest FDA-approved treatments. The Centers are built to support diverse clinical needs, with specialties in neurology, gastroenterology, rheumatology, dermatology, immunology, pulmonology, ophthalmology, and endocrinology. In Marietta, patients will find private treatment rooms for added comfort, flexible scheduling options, and highly skilled clinical staff.

“At AIC, we understand that infusion therapy is more than a procedure—it’s an essential part of a patient’s overall health and quality of life,” said Jud Hall, President of AIC. “Our approach is centered on reducing wait times and increasing meaningful care. With private rooms, adaptable appointment options, and highly trained medical professionals, we ensure that every patient receives care designed around their needs.”

As a full-service partner to clinicians, AIC works collaboratively with provider offices, insurance companies, and patients to secure all required authorizations and approvals. Dual accreditation from URAC and the Accreditation Commission for Health Care (ACHC) further sets AIC apart as a trusted leader in infusion care.

About AIS Healthcare

Advancing quality. Improving lives.

As the leading provider of targeted drug delivery and infusion care solutions, AIS Healthcare is committed to doing more of what matters. From pharmacies that put patient safety first to comprehensive services that enhance the entire care experience, we go beyond the expected in everything we do.

Learn more at aiscaregroup.com.

Contacts

Jud Hall

877.443.4006

Market Opportunity
AI COMPANIONS Logo
AI COMPANIONS Price(AIC)
$0.0491
$0.0491$0.0491
-7.09%
USD
AI COMPANIONS (AIC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Zcash (ZEC) Price Prediction: ZEC Defends $300 Support as Bullish Structures and Privacy Narrative Return to Focus

Zcash (ZEC) Price Prediction: ZEC Defends $300 Support as Bullish Structures and Privacy Narrative Return to Focus

Zcash (ZEC) is holding above the crucial $300 support zone as price consolidates near $339, with traders watching key resistance levels and a potential bullish
Share
Brave New Coin2026/02/01 02:16
The 5000x Potential: BlockDAG Enters Its Final Hours at $0.0005 Before the Presale Ends

The 5000x Potential: BlockDAG Enters Its Final Hours at $0.0005 Before the Presale Ends

BlockDAG is one of the few projects offering a structured window rather than a surprise. The presale has already raised $452 million, and only hours remain to buy
Share
Techbullion2026/02/01 02:00
Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC

The post Franklin Templeton CEO Dismisses 50bps Rate Cut Ahead FOMC appeared on BitcoinEthereumNews.com. Franklin Templeton CEO Jenny Johnson has weighed in on whether the Federal Reserve should make a 25 basis points (bps) Fed rate cut or 50 bps cut. This comes ahead of the Fed decision today at today’s FOMC meeting, with the market pricing in a 25 bps cut. Bitcoin and the broader crypto market are currently trading flat ahead of the rate cut decision. Franklin Templeton CEO Weighs In On Potential FOMC Decision In a CNBC interview, Jenny Johnson said that she expects the Fed to make a 25 bps cut today instead of a 50 bps cut. She acknowledged the jobs data, which suggested that the labor market is weakening. However, she noted that this data is backward-looking, indicating that it doesn’t show the current state of the economy. She alluded to the wage growth, which she remarked is an indication of a robust labor market. She added that retail sales are up and that consumers are still spending, despite inflation being sticky at 3%, which makes a case for why the FOMC should opt against a 50-basis-point Fed rate cut. In line with this, the Franklin Templeton CEO said that she would go with a 25 bps rate cut if she were Jerome Powell. She remarked that the Fed still has the October and December FOMC meetings to make further cuts if the incoming data warrants it. Johnson also asserted that the data show a robust economy. However, she noted that there can’t be an argument for no Fed rate cut since Powell already signaled at Jackson Hole that they were likely to lower interest rates at this meeting due to concerns over a weakening labor market. Notably, her comment comes as experts argue for both sides on why the Fed should make a 25 bps cut or…
Share
BitcoinEthereumNews2025/09/18 00:36